Amneal Pharmaceuticals (AMRX) Operating Margin (2017 - 2025)
Historic Operating Margin for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to 8.97%.
- Amneal Pharmaceuticals' Operating Margin fell 36800.0% to 8.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.19%, marking a year-over-year increase of 51900.0%. This contributed to the annual value of 8.92% for FY2024, which is 3900.0% up from last year.
- According to the latest figures from Q3 2025, Amneal Pharmaceuticals' Operating Margin is 8.97%, which was down 36800.0% from 15.37% recorded in Q2 2025.
- In the past 5 years, Amneal Pharmaceuticals' Operating Margin ranged from a high of 15.37% in Q2 2025 and a low of 35.51% during Q2 2022
- Moreover, its 5-year median value for Operating Margin was 8.97% (2025), whereas its average is 6.33%.
- Its Operating Margin has fluctuated over the past 5 years, first tumbled by -480500bps in 2022, then surged by 488800bps in 2023.
- Over the past 5 years, Amneal Pharmaceuticals' Operating Margin (Quarter) stood at 2.08% in 2021, then skyrocketed by 184bps to 5.91% in 2022, then plummeted by -61bps to 2.3% in 2023, then skyrocketed by 351bps to 10.38% in 2024, then fell by -14bps to 8.97% in 2025.
- Its Operating Margin stands at 8.97% for Q3 2025, versus 15.37% for Q2 2025 and 14.43% for Q1 2025.